Why hasn't eliminating acute rejection improved graft survival?

JogiRaju Tantravahi, Karl L. Womer, Bruce Kaplan

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Although patients with end-stage renal disease can be maintained with dialysis therapy, the superiority of patient survival with renal transplantation makes transplantation the preferred method of renal replacement. Potent immunosuppressive therapies, particularly calcineurin inhibitors, have greatly reduced the incidence of acute rejection. However, long-term allograft survival remains limited. We discuss the impact of acute rejection on long-term allograft survival and discuss other factors leading to late allograft loss, including calcineurin inhibitor toxicity, chronic allograft nephropathy, and BK virus nephropathy, as well as donor and recipient factors associated with long-term allograft loss.

Original languageEnglish (US)
Pages (from-to)369-385
Number of pages17
JournalAnnual Review of Medicine
Volume58
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Graft Survival
Grafts
Allografts
BK Virus
Dialysis
Immunosuppressive Agents
Viruses
Kidney Transplantation
Chronic Kidney Failure
Toxicity
Transplantation
Tissue Donors
Kidney
Survival
Incidence
Therapeutics
Calcineurin Inhibitors

Keywords

  • Allograft survival
  • BK virus nephropathy
  • Calcineurin inhibitor toxicity
  • Chronic allograft nephropathy
  • Donor and recipient factors
  • Kidney transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Why hasn't eliminating acute rejection improved graft survival? / Tantravahi, JogiRaju; Womer, Karl L.; Kaplan, Bruce.

In: Annual Review of Medicine, Vol. 58, 2007, p. 369-385.

Research output: Contribution to journalArticle

Tantravahi, JogiRaju ; Womer, Karl L. ; Kaplan, Bruce. / Why hasn't eliminating acute rejection improved graft survival?. In: Annual Review of Medicine. 2007 ; Vol. 58. pp. 369-385.
@article{711ae8b89aa64979aa4a5f188438b6a9,
title = "Why hasn't eliminating acute rejection improved graft survival?",
abstract = "Although patients with end-stage renal disease can be maintained with dialysis therapy, the superiority of patient survival with renal transplantation makes transplantation the preferred method of renal replacement. Potent immunosuppressive therapies, particularly calcineurin inhibitors, have greatly reduced the incidence of acute rejection. However, long-term allograft survival remains limited. We discuss the impact of acute rejection on long-term allograft survival and discuss other factors leading to late allograft loss, including calcineurin inhibitor toxicity, chronic allograft nephropathy, and BK virus nephropathy, as well as donor and recipient factors associated with long-term allograft loss.",
keywords = "Allograft survival, BK virus nephropathy, Calcineurin inhibitor toxicity, Chronic allograft nephropathy, Donor and recipient factors, Kidney transplantation",
author = "JogiRaju Tantravahi and Womer, {Karl L.} and Bruce Kaplan",
year = "2007",
doi = "10.1146/annurev.med.58.061705.145143",
language = "English (US)",
volume = "58",
pages = "369--385",
journal = "Annual Review of Medicine",
issn = "0066-4219",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Why hasn't eliminating acute rejection improved graft survival?

AU - Tantravahi, JogiRaju

AU - Womer, Karl L.

AU - Kaplan, Bruce

PY - 2007

Y1 - 2007

N2 - Although patients with end-stage renal disease can be maintained with dialysis therapy, the superiority of patient survival with renal transplantation makes transplantation the preferred method of renal replacement. Potent immunosuppressive therapies, particularly calcineurin inhibitors, have greatly reduced the incidence of acute rejection. However, long-term allograft survival remains limited. We discuss the impact of acute rejection on long-term allograft survival and discuss other factors leading to late allograft loss, including calcineurin inhibitor toxicity, chronic allograft nephropathy, and BK virus nephropathy, as well as donor and recipient factors associated with long-term allograft loss.

AB - Although patients with end-stage renal disease can be maintained with dialysis therapy, the superiority of patient survival with renal transplantation makes transplantation the preferred method of renal replacement. Potent immunosuppressive therapies, particularly calcineurin inhibitors, have greatly reduced the incidence of acute rejection. However, long-term allograft survival remains limited. We discuss the impact of acute rejection on long-term allograft survival and discuss other factors leading to late allograft loss, including calcineurin inhibitor toxicity, chronic allograft nephropathy, and BK virus nephropathy, as well as donor and recipient factors associated with long-term allograft loss.

KW - Allograft survival

KW - BK virus nephropathy

KW - Calcineurin inhibitor toxicity

KW - Chronic allograft nephropathy

KW - Donor and recipient factors

KW - Kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=34047171006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047171006&partnerID=8YFLogxK

U2 - 10.1146/annurev.med.58.061705.145143

DO - 10.1146/annurev.med.58.061705.145143

M3 - Article

VL - 58

SP - 369

EP - 385

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -